S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
NASDAQ:BSGM

BioSig Technologies - BSGM Stock Forecast, Price & News

$1.00
+0.06 (+6.00%)
(As of 02/3/2023 09:03 PM ET)
Add
Compare
Today's Range
$0.94
▼
$1.00
50-Day Range
$0.41
▼
$1.00
52-Week Range
$0.25
▼
$1.73
Volume
197,700 shs
Average Volume
251,622 shs
Market Capitalization
$54.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

BioSig Technologies MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
100.9% Upside
$2.00 Price Target
Short Interest
Healthy
1.75% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.59) to ($0.34) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Medical Sector

466th out of 1,025 stocks

Electromedical Equipment Industry

12th out of 24 stocks

See Top Rated MarketRank™ Stocks Here
BSGM stock logo

About BioSig Technologies (NASDAQ:BSGM) Stock

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.

Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSGM Stock News Headlines

January 19, 2023 | finance.yahoo.com
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
December 14, 2022 | finance.yahoo.com
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
February 6, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
December 14, 2022 | finance.yahoo.com
It's Unlikely That BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Will See A Huge Pay Rise This Year
December 14, 2022 | finance.yahoo.com
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
December 6, 2022 | finance.yahoo.com
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
October 24, 2022 | finance.yahoo.com
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
October 12, 2022 | finance.yahoo.com
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
February 6, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
October 7, 2022 | finance.yahoo.com
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base
October 1, 2022 | seekingalpha.com
BSGM BioSig Technologies, Inc.
September 22, 2022 | finance.yahoo.com
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
September 16, 2022 | finance.yahoo.com
Taglich Brothers Initiates Coverage of BioSig Technologies, Inc.
September 9, 2022 | finance.yahoo.com
The Zacks Analyst Blog Highlights ShockWave Medical, CheckCap and Biosig Technologies
September 8, 2022 | finance.yahoo.com
3 Medical Instruments Stocks With Potential to Outperform
August 30, 2022 | finance.yahoo.com
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
August 24, 2022 | finance.yahoo.com
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
August 17, 2022 | finance.yahoo.com
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022
August 16, 2022 | finance.yahoo.com
BioSig Sees Positive Momentum from Sales Pipeline Growth
August 6, 2022 | finance.yahoo.com
BioSig Technologies, Inc. (BSGM)
July 21, 2022 | finance.yahoo.com
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute
July 7, 2022 | finance.yahoo.com
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
June 24, 2022 | proactiveinvestors.com
BioSig Technologies prices previously announced "best efforts" underwritten public offering to raise around $3.5M gross
June 24, 2022 | seekingalpha.com
BioSig Technologies stock slides on $3.5M share offering
June 23, 2022 | seekingalpha.com
BioSig Technologies proposes stock offering to ramp up PURE EP commercialization
June 22, 2022 | seekingalpha.com
BioSig enters new evaluation agreement for PURE EP with Cleveland clinic
June 22, 2022 | proactiveinvestors.com
BioSig Technologies enters deal for Cleveland Clinic to evaluate its PURE EP signal processing platform
See More Headlines
Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSGM Company Calendar

Last Earnings
11/14/2022
Today
2/05/2023
Next Earnings (Estimated)
2/13/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BSGM
CUSIP
N/A
CIK
1530766
Web
www.biosig.com
Phone
(230) 409-5444
Fax
N/A
Employees
49
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+100.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-31,920,000.00
Net Margins
-18,074.21%
Pretax Margin
-18,405.66%
Return on Equity
-380.63%
Return on Assets
-273.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.22
Quick Ratio
0.55

Sales & Book Value

Annual Sales
$159,000.00
Price / Sales
341.67
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.35 per share
Price / Book
2.84

Miscellaneous

Outstanding Shares
54,577,000
Free Float
48,093,000
Market Cap
$54.33 million
Optionable
Not Optionable
Beta
1.50

Key Executives

  • Kenneth L. LondonerKenneth L. Londoner
    Executive Chairman & Chief Executive Officer
  • John Sieckhaus
    Chief Operating Officer
  • Steven ChaussySteven Chaussy
    Chief Financial Officer
  • Budimir S. Drakulic
    Chief Scientist
  • Zachary Koch
    Clinical Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













BSGM Stock - Frequently Asked Questions

Should I buy or sell BioSig Technologies stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSGM shares.
View BSGM analyst ratings or view top-rated stocks.

What is BioSig Technologies' stock price forecast for 2023?

1 Wall Street research analysts have issued twelve-month target prices for BioSig Technologies' stock. Their BSGM share price forecasts range from $2.00 to $2.00. On average, they expect the company's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 100.9% from the stock's current price.
View analysts price targets for BSGM or view top-rated stocks among Wall Street analysts.

How have BSGM shares performed in 2023?

BioSig Technologies' stock was trading at $0.42 at the start of the year. Since then, BSGM stock has increased by 137.0% and is now trading at $0.9954.
View the best growth stocks for 2023 here.

When is BioSig Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023.
View our BSGM earnings forecast.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) released its quarterly earnings results on Monday, November, 14th. The company reported ($0.14) EPS for the quarter, meeting analysts' consensus estimates of ($0.14). The firm earned $0.14 million during the quarter, compared to analysts' expectations of $0.59 million. BioSig Technologies had a negative net margin of 18,074.21% and a negative trailing twelve-month return on equity of 380.63%.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Mayo Clinic (0.18%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, Jerome B Zeldis, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Martha Pease, Patrick Joseph Gallagher and Steve Chaussy.
View institutional ownership trends.

How do I buy shares of BioSig Technologies?

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioSig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $1.00.

How much money does BioSig Technologies make?

BioSig Technologies (NASDAQ:BSGM) has a market capitalization of $54.33 million and generates $159,000.00 in revenue each year.

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The official website for the company is www.biosig.com. The company can be reached via phone at (230) 409-5444 or via email at info@biosigtech.com.

This page (NASDAQ:BSGM) was last updated on 2/6/2023 by MarketBeat.com Staff